Evidence map›Paper›PMID 33406505›Full record

ArticleAging2020

Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway.

Li Shi, Rui Zhang, Tian Li, Xue Han, Nannan Yuan, Lei Jiang, Huimin Zhou, Shunjiang Xu

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Biochemical and Molecular Markers Among Prediabetic and Type 2 Diabetes Mellitus Patients.International journal of endocrinology and metabolism · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Metabolic memory: mechanisms and diseases.Signal transduction and targeted therapy · 2024
    Review
  10. Article
  11. Review
  12. An autophagy-related lncRNA prognostic risk model for thyroid cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Li ShiDepartment of Endocrinology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Rui ZhangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Tian LiSchool of Basic Medicine, The Fourth Military Medical University, Xi'an 710032, China.
Xue HanDepartment of General Practice, Xingtai People's Hospital, Xingtai 054000, China.
Nannan YuanCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Lei JiangCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Huimin ZhouDepartment of Endocrinology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Shunjiang XuCentral Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Hebei Medical University · CNAir Force Medical University · CNXingtai People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic encephalopathy (DE) is a global concern and Gordian knot worldwide. miRNA-132 (miR-132) is a class of negative gene regulators that promote diabetic pathologic mechanisms and its complications. However, the molecular mechanisms of miR-132 in DE are elusive, thus an alternative therapeutic strategy is urgently in demand. The present study explored the protective effect and the underlying mechanism of miR-132 on DE via the GSK-β/Tau signaling pathway. Experimentally, a type 2 DM rat model was developed by incorporating a high-fat diet and streptozotocin injection. Further, the DE model was screened via the Morris Water Maze test. Primary hippocampal neurons and HT-22 cells were used for

Indexed as

MicroRNAsAnimalsBrain DiseasesCell LineCells, CulturedDiabetes ComplicationsDown-RegulationGlycogen Synthase Kinase 3 betaHippocampusHyperglycemiaMaze LearningNeuronsRatsSignal Transductiontau ProteinsGlycogen Synthase Kinase 3 betaMapt protein, ratMicroRNAstau ProteinsAlzheimer’s diseasediabetic encephalopathyGSK-3βmiRNA-132tau hyperphosphorylation

Identifiers

PMID33406505
PMCPMC7906212
OpenAlexW3113584458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.